Keyword: Bystolic

Allergan California

6. Bystolic

Of the $640.5 million Bystolic generated in 2016 for Allergan, $638.8 million came from the U.S. Evaluate Pharma predicts the med will rack up just $214 million in 2022, or $591 million if other versions marketed by Menarini are counted.
human heart

Special Report—The top 10 cardiovascular drugs in the world

Cardiovascular drugs may not be the top field in terms of sales or market growth rate. But heart disease and related ailments remain the biggest cause of death in the U.S. We’ve put together this list as a state-of-the-market snapshot, coinciding with the European Society of Cardiology meeting this week.